Avita Medical (AVH) is an Australian incorporated medical device company listed on ASX focussing on the development of its ReCell regenerative skin technology.

We acted on the divestment of AVH’s non-core respiratory business to Medical Developments International for $2.64 million in 2015 and on its non-renounceable rights issue to raise $5 million in June 2016, and we continue to act on general corporate matters.